InMed Pharmaceuticals, Inc. (INM)
1.73
+0.12
(+7.45%)
USD |
NASDAQ |
May 21, 16:00
1.78
+0.05
(+2.89%)
After-Hours: 07:48
InMed Pharmaceuticals EPS Diluted (Quarterly) : -0.7327 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -0.0006 |
| Lexaria Bioscience Corp. | -0.0593 |
| Target Group, Inc. (Canada) | -0.0009 |
| Tilray Brands, Inc. | -0.2358 |
| NervGen Pharma Corp. | -0.0153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.792M |
| Total Expenses (Quarterly) | 2.792M |
| Enterprise Value | 0.9529M |
| Earnings Yield | -148.9% |
| Normalized Earnings Yield | -148.87 |